File Download
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: Antiretroviral treatment can affect the release of NO and EDCF, but EDH in rat arteries
| Title | Antiretroviral treatment can affect the release of NO and EDCF, but EDH in rat arteries |
|---|---|
| Authors | |
| Keywords | Medical sciences Cardiovascular diseases |
| Issue Date | 2012 |
| Publisher | S Karger AG. The Journal's web site is located at http://www.karger.com/JVR |
| Citation | The 10th Anniversary EDHF Meeting (EDHF 2012), Vaux-de-Cernay, France, 27-30 June 2012. In Journal of Vascular Research, 2012, v. 49 suppl. 2, abstract no. 37 How to Cite? |
| Abstract | Despite improving clinical outcomes, highly active antiretroviral therapy (HAART) is an
independent potential risk factor for cardiovascular diseases. Currently the recommended HAART
regimen commonly comprises a protease inhibitor (PI) with ritonavir (RTV)-boosting or a nonnucleoside
reverse transcriptase inhibitor (NNRTI), and two nucleoside reverse transcriptase
inhibitors. The present study examined whether or not boosted lopin... |
| Description | This journal suppl. entitled: EDHF 2012 - 10th Anniversary Meeting |
| Persistent Identifier | http://hdl.handle.net/10722/165630 |
| ISSN | 2021 Impact Factor: 2.045 2020 SCImago Journal Rankings: 0.580 |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Nejad, A | en_US |
| dc.contributor.author | Lee, SS | en_US |
| dc.contributor.author | Vanhoutte, PM | en_US |
| dc.contributor.author | Leung, SWS | en_US |
| dc.date.accessioned | 2012-09-20T08:21:22Z | - |
| dc.date.available | 2012-09-20T08:21:22Z | - |
| dc.date.issued | 2012 | en_US |
| dc.identifier.citation | The 10th Anniversary EDHF Meeting (EDHF 2012), Vaux-de-Cernay, France, 27-30 June 2012. In Journal of Vascular Research, 2012, v. 49 suppl. 2, abstract no. 37 | en_US |
| dc.identifier.issn | 1018-1172 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/165630 | - |
| dc.description | This journal suppl. entitled: EDHF 2012 - 10th Anniversary Meeting | - |
| dc.description.abstract | Despite improving clinical outcomes, highly active antiretroviral therapy (HAART) is an independent potential risk factor for cardiovascular diseases. Currently the recommended HAART regimen commonly comprises a protease inhibitor (PI) with ritonavir (RTV)-boosting or a nonnucleoside reverse transcriptase inhibitor (NNRTI), and two nucleoside reverse transcriptase inhibitors. The present study examined whether or not boosted lopin... | - |
| dc.language | eng | en_US |
| dc.publisher | S Karger AG. The Journal's web site is located at http://www.karger.com/JVR | - |
| dc.relation.ispartof | Journal of Vascular Research | en_US |
| dc.rights | Journal of Vascular Research. Copyright © S Karger AG. | - |
| dc.subject | Medical sciences | - |
| dc.subject | Cardiovascular diseases | - |
| dc.title | Antiretroviral treatment can affect the release of NO and EDCF, but EDH in rat arteries | en_US |
| dc.type | Conference_Paper | en_US |
| dc.identifier.email | Vanhoutte, PM: vanhoutt@hku.hk | en_US |
| dc.identifier.email | Leung, SWS: swsleung@hku.hk | en_US |
| dc.identifier.authority | Vanhoutte, PM=rp00238 | en_US |
| dc.identifier.authority | Leung, SWS=rp00235 | en_US |
| dc.description.nature | postprint | - |
| dc.identifier.doi | 10.1159/000339218 | - |
| dc.identifier.hkuros | 211038 | en_US |
| dc.identifier.volume | 49 | - |
| dc.identifier.issue | suppl. 2 | - |
| dc.publisher.place | Switzerland | - |
| dc.identifier.issnl | 1018-1172 | - |